-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Data in 2020 show that the annual number of strokes in the United States is about 795,000, of which 23% are recurrent strokes, and 87% of them are ischemic strokes
.
Data from 2014 show that 12% of stroke patients have atrial fibrillation (AF).
In recent days, researchers have followed up for 12 months to determine the risk of atrial fibrillation in stroke patients with large or small vessel disease
STROKE-AF is carried out in 33 clinical centers in the United States.
Patients are 60 years old or older, or are between 50 and 59 years old and have at least one risk factor for stroke.
The patient has serious symptoms within 10 days before receiving cardiac monitoring.
Stroke caused by vascular or small vessel disease
.
Patients were randomly divided into intervention group (n=242, receiving implanted circulatory monitoring within 10 days after stroke) or control group (n=250, receiving routine care on site, such as ECG, Holter monitoring, etc.
The average age of the patients was 67.
1 years, 185 cases (37.
6%) were women, and 417 cases (84.
8%) completed the 12-month follow-up
.
The average CHA2DS2 VASc score is 5
At 12 months, the detection rate of atrial fibrillation in the implanted circulatory monitoring group was significantly higher than that in the control group (27 cases [12.
Differences in AF detection rates between groups
Studies believe that the incidence of atrial fibrillation at 12 months for stroke patients caused by large or small vessel diseases is higher than previously recognized.
Implantable circulatory monitoring has greatly increased the detection rate of atrial fibrillation.
Further research is needed in the future.
Identify whether additional atrial fibrillation events are clinically meaningful
.
Implantable circulatory monitoring has greatly improved the detection rate of atrial fibrillation.
Further research is needed to identify additional ones in the future.
Whether the atrial fibrillation event has clinical significance
.
For stroke patients caused by large or small vessel diseases, the 12-month incidence of atrial fibrillation is higher than previously recognized.
Original source:
Richard A.
Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease The STROKE-AF Randomized Clinical Trial.
JAMA Leave a message here